atg-010
Showing 1 - 2 of 2
Relapse/Refractory Multiple Myeloma Trial in China (ATG-010)
Completed
- Relapse/Refractory Multiple Myeloma
- ATG-010
-
Beijing, Beijing, China
- +16 more
Jul 27, 2022
1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer Trial in Chongqing (ATG-008,
Not yet recruiting
- 1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer
- ATG-008
- ATG-010
-
Chongqing, Chongqing, ChinaChongqing Cancer Hospital
Aug 4, 2021